Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results - Fleischer, David M.; Shreffler, Wayne G.; Campbell, Dianne E.; Green, Todd D.; Anvari, Sara; Assa’ad, Amal; Bégin, Philippe; Beyer, Kirsten; Bird, J. Andrew; Brown-Whitehorn, Terri; Byrne, Aideen; Chan, Edmond S.; et al. (Journal of allergy and clinical immunology, 2020)
Keywords: Administration, Cutaneous; Adolescent; Allergens - administration & dosage; Allergens - immunology; Biomarkers; Child; Child, Preschool; desensitization; Desensitization, Immunologic - adverse effects; Desensitization, Immunologic - methods; eliciting dose; epicutaneous immunotherapy; EPIT; Female; Follow-Up Studies; food allergy; Humans; Immunoglobulin E - immunology; immunotherapy; Male; Peanut allergy; Peanut Hypersensitivity - immunology; Peanut Hypersensitivity - therapy; sustained unresponsiveness; Treatment Outcome; PP; sIgE; SU; AE; HRQL; epicutaneous immunotherapy; IQR; food allergy; desensitization; mLOCF; eliciting dose; TEAE; CRD; Peanut allergy; EPIT; immunotherapy; sustained unresponsiveness; DBPCFC; ED